ArticleJournal of clinical medicine research2024

Elevated Serum Growth Differentiation Factor 15 Levels as a Potential Biomarker of the Efficacy of Imeglimin in Individuals With Type 2 Diabetes Mellitus: An Exploratory Study.

Naoki Wada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.